Does Chemotherapy Affects Human Corneal Grafts?
Published 2022 - 40th Congress of the ESCRS
Reference: PO247 | Type: ESCRS 2022 - Posters | DOI: 10.82333/d1dm-0z49
Authors: Georgios S. Dimtsas* 1 , Xanthippi Grammatoglou 2 , Theodosia Choreftaki 2 , Ioanna Gourgouli 3 , Marilita Moschos 1
11st Department of Ophthalmology University of Athens, Medical School,General Hospital of Athens "G. Gennimatas",Athens,Greece, 2Department of Pathology,General Hospital of Athens "G. Gennimatas",Athens,Greece, 3Department of Ophthalmology ,General Hospital "Sismanoglio",Athens,Greece
Purpose
The aim of our study was to examine, for the first time in literature, any structural differences in the integrity of the corneal grafts from donors who have received and from those who have not received chemotherapy. CD44, the hyaluronan receptor, is a transmembrane glycoprotein which was recognized as a cell adhesion receptor that plays a key role in cell–cell and cell–matrix interactions, cell migration, lymphocyte homing and activation, tumor growth and metastasis. The main haematopoietic form of CD44 has a molecular weight of 85-95 kDa. CD44 is related with the maintenance of normal tissue structure and the proliferative potency of the epithelium.
Setting
Methods
Results
Conclusions